The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells

Cancer Science

Volumn 99, Issue 4, 2008, Pages 762-769

  Guay, David ^a   Garand, Chantal ^a   Reddy, Shanti ^b   Schmutte, Chris ^b   Lebel, Michel ^a  

^a LAVAL UNIVERSITY   (Canada)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CISPLATIN; ENDONUCLEASE; ENDONUCLEASE III; MITOMYCIN C; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1;

ARTICLE; CELL PROLIFERATION; CHROMATOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG MECHANISM; DRUG POTENTIATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; TUMOR CELL; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DEOXYRIBONUCLEASE (PYRIMIDINE DIMER); DRUG RESISTANCE, NEOPLASM; HUMANS; MITOMYCIN; NEOPLASMS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; RNA, SMALL INTERFERING; ULTRAVIOLET RAYS; Y-BOX-BINDING PROTEIN 1;

EID: 41349108483     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00739.x     Document Type: Article

References (29)

1. Swamynathan SK, Nambiar A, Guntaka RV. Role of single-stranded DNA regions and Y-box proteins in transcriptional regulation of viral and cellular genes. FASEB J 1998; 12: 515-22.
2. Ashizuka M, Fukuda T, Nakamura T et al. Novel translational control through an iron-responsive element by interaction of multifunctional protein YB-1 and IRP2. Mol Cell Biol 2002; 22: 6375-83.
3. Stickeler E, Fraser SD, Honig A, Chen AL, Berget SM, Cooper TA. The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4. EMBO J 2001; 20: 3821-30.
4. Hayakawa H, Uchiumi T, Fukuda T et al. Binding capacity of human YB-1 protein for RNA containing 8-oxoguanine. Biochemistry 2002; 41: 12739-44.
5. Koike K, Uchiumi T, Ohga T et al. Nuclear translocation of the Y-box binding protein by ultraviolet irradiation. FEBS Lett 1997; 417: 390-4.
6. Bargou RC, Jurchott K, Wagener C et al. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 1997; 3: 447-50.
7. Janz M, Harbeck N, Dettmar P et al. Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Int J Cancer 2002; 97: 278-82.
8. Oda Y, Ohishi Y, Saito T et al. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma. J Pathol 2003; 199: 251-8.
9. Rubinstein DB, Stortchevoi A, Boosalis M, Ashfaq R, Guillaume T. Overexpression of DNA-binding protein B gene product in breast cancer as detected by in vitro-generated combinatorial human immunoglobulin libraries. Cancer Res 2002; 62: 4985-91.
10. Yahata H, Kobayashi H, Kamura T et al. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer. J Cancer Res Clin Oncol 2002; 128: 621-6.
11. Ohga T, Uchiumi T, Makino Y et al. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J Biol Chem 1998; 273: 5997-6000.
12. Gaudreault I, Guay D, Lebel M. YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins. Nucl Acids Res 2004; 32: 316-27.
13. Marenstein DR, Ocampo MT, Chan MK et al. Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B). Interaction between a base excision repair enzyme and a transcription factor. J Biol Chem 2001; 276: 21242-9.
14. Marenstein DR, Chan MK, Altamirano A et al. Substrate specificity of human endonuclease III (hNTH1). Effect of human APE1 on hNTH1 activity. J Biol Chem 2003; 278: 9005-12.
15. Ohga T, Koike K, Ono M et al. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res 1996; 56: 4224-8.
16. Schmutte C, Sadoff MM, Shim KS, Acharya S, Fishel R. Role of the human Y-box binding protein YB-1 in cellular sensitivity to DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. J Biol Chem 2001; 276: 33011-8.
17. Moggs JG, Yarema KJ, Essigmann JM, Wood RD. Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d (GpTpG) -cisplatin adduct. J Biol Chem 1996; 271: 7177-86.
18. Izumi H, Imamura T, Nagatani G et al. Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3′→5′ exonuclease activity. Nucl Acids Res 2001; 29: 1200-7.
19. Liu X, Choudhury S, Roy R. In vitro and in vivo dimerization of human endonuclease III stimulates its activity. J Biol Chem 2003; 278: 50061-9.
20. Martins NM, Santos NA, Curti C, Bianchi ML, Santos AC. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J Appl Toxicol 2007 [Epub ahead of print].
21. Sasada T, Iwata S, Sato N et al. Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): Protective effect of human thioredoxin against CDDP-induced cytotoxicity. J Clin Invest 1996; 97: 2268-76.
22. Jurchott K, Bergmann S, Stein U et al. YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression. J Biol Chem 2003; 278: 27988-96.
23. Bader AG, Vogt PK. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation. Mol Cell Biol 2005; 25: 2095-106.
24. Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat Res 2001; 478: 23-43.
25. Shibahara K, Uchiumi T, Fukuda T et al. Targeted disruption of one allele of the Y-box binding protein-1 (YB-1) gene in mouse embryonic stem cells and increased sensitivity to cisplatin and mitomycin C. Cancer Sci 2004; 95: 348-53.
26. Sutherland BW, Kucab J, Wu J et al. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 2005; 24: 4281-92.
27. Winograd-Katz SE, Levitzki A. Cisplatin induces PKB/Akt activation and p38 (MAPK) phosphorylation of the EGF receptor. Oncogene 2006; 25: 7381-90.
28. Wan YS, Wang ZQ, Shao Y, Voorhees JJ, Fisher GJ. Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo. Int J Oncol 2001; 18: 461-6.
29. Madhusudan S, Smart F, Shrimpton P et al. Isolation of a small molecule inhibitor of DNA base excision repair. Nucl Acids Res 2005; 33: 4711-24.